We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Increased plasma amyloid beta protein 1-42 levels in Down syndrome.
Neuroscience Letters 1998 January 24
Amyloid beta protein 1-40 (A beta40) and A beta42 levels were quantitated in plasma from 43 persons with Down syndrome (DS; 26-68 years of age), 43 age-matched normal controls, and 19 non-DS mentally retarded (MR) persons (26-91 years of age) by using a sandwich enzyme linked immunosorbent assay. A beta40 levels were higher in DS and MR than controls, but were similar between DS and MR groups. A beta42 levels were higher in DS than controls or MR persons. The ratios of A beta42/A beta40 were higher in DS than controls or MR persons. The findings are consistent with those seen in DS brains.
Full text links
Related Resources
Trending Papers
Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding.European Journal of Anaesthesiology 2024 May 2
Aspiration under anesthesia: what happens after we sound the glucagon-like peptide-1 receptor agonist alarm?Canadian Journal of Anaesthesia 2024 August 27
Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.JAMA 2024 August 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app